These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 18210023)
41. Colorectal cancer screening in a low-incidence area: general invitation versus family risk targeting: a comparative study from Montenegro. Panic N; Rösch T; Smolovic B; Radunovic M; Bulajic M; Pavlovic-Markovic A; Krivokapic Z; Djuranovic S; Ille T; Bulajic M Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1222-5. PubMed ID: 26067224 [TBL] [Abstract][Full Text] [Related]
42. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology. Bampton PA; Sandford JJ; Cole SR; Smith A; Morcom J; Cadd B; Young GP Gut; 2005 Jun; 54(6):803-6. PubMed ID: 15888788 [TBL] [Abstract][Full Text] [Related]
43. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme. Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502 [TBL] [Abstract][Full Text] [Related]
44. Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018. Vangala DB; Cauchin E; Balmaña J; Wyrwicz L; van Cutsem E; Güller U; Castells A; Carneiro F; Hammel P; Ducreux M; van Laethem JL; Matysiak-Budnik T; Schmiegel W Eur J Cancer; 2018 Nov; 104():91-103. PubMed ID: 30342310 [TBL] [Abstract][Full Text] [Related]
45. Lower gastrointestinal symptoms are not predictive of colorectal neoplasia in a faecal occult blood screen-positive population. Ahmed S; Leslie A; Thaha MA; Carey FA; Steele RJ Br J Surg; 2005 Apr; 92(4):478-81. PubMed ID: 15609377 [TBL] [Abstract][Full Text] [Related]
46. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Tinmouth J; Lansdorp-Vogelaar I; Allison JE Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750 [TBL] [Abstract][Full Text] [Related]
47. Progress in chemoprevention of gastrointestinal cancers. Tempero MA Curr Opin Oncol; 1991 Aug; 3(4):719-26. PubMed ID: 1834193 [TBL] [Abstract][Full Text] [Related]
48. Helicobacter pylori and Gastric Cancer: Timing and Impact of Preventive Measures. Venerito M; Vasapolli R; Malfertheiner P Adv Exp Med Biol; 2016; 908():409-18. PubMed ID: 27573783 [TBL] [Abstract][Full Text] [Related]
49. Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study. Imperiale TF; Monahan PO; Stump TE; Glowinski EA; Ransohoff DF Ann Intern Med; 2015 Sep; 163(5):339-46. PubMed ID: 26259154 [TBL] [Abstract][Full Text] [Related]
50. Tumour markers and screening for gastrointestinal cancer: a follow up study in Finland. Hakama M; Stenman UH; Knekt P; Järvisalo J; Leino A; Hakulinen T; Maatela J; Aromaa A J Med Screen; 1994 Jan; 1(1):60-4. PubMed ID: 8790487 [TBL] [Abstract][Full Text] [Related]
51. Colonoscopy screening in the elderly: when to stop? Stevens T; Burke CA Am J Gastroenterol; 2003 Aug; 98(8):1881-5. PubMed ID: 12907348 [TBL] [Abstract][Full Text] [Related]
52. Incidence of Advanced Colorectal Neoplasia in Individuals With Untreated Diminutive Colorectal Adenomas Diagnosed by Magnifying Image-Enhanced Endoscopy. Sekiguchi M; Otake Y; Kakugawa Y; Matsumoto M; Tomizawa Y; Saito Y; Matsuda T Am J Gastroenterol; 2019 Jun; 114(6):964-973. PubMed ID: 31082873 [TBL] [Abstract][Full Text] [Related]
53. [Effectiveness of screening colonoscopy in a community-based study]. Hüppe D; Hartmann H; Felten G; Kemen M; Tannapfel A; Gillessen A; Katalinic A Z Gastroenterol; 2008 Feb; 46(2):193-200. PubMed ID: 18253898 [TBL] [Abstract][Full Text] [Related]
54. Patient- and procedure-related factors affecting proximal and distal detection rates for polyps and adenomas: results from 1603 screening colonoscopies. Schramm C; Mbaya N; Franklin J; Demir M; Kuetting F; Toex U; Goeser T; Steffen HM Int J Colorectal Dis; 2015 Dec; 30(12):1715-22. PubMed ID: 26272199 [TBL] [Abstract][Full Text] [Related]
55. Colorectal Cancer Screening and Prevention. Wilkins T; McMechan D; Talukder A Am Fam Physician; 2018 May; 97(10):658-665. PubMed ID: 29763272 [TBL] [Abstract][Full Text] [Related]
56. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients. Genta RM; Schuler CM; Robiou CI; Lash RH Clin Gastroenterol Hepatol; 2009 Aug; 7(8):849-54. PubMed ID: 19465154 [TBL] [Abstract][Full Text] [Related]
57. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases. Siripongpreeda B; Mahidol C; Dusitanond N; Sriprayoon T; Muyphuag B; Sricharunrat T; Teerayatanakul N; Chaiwong W; Worasawate W; Sattayarungsee P; Sangthongdee J; Prarom J; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU BMC Gastroenterol; 2016 Aug; 16(1):101. PubMed ID: 27553627 [TBL] [Abstract][Full Text] [Related]
58. [Comparative study of two rounds of colorectal cancer screening in 80, 000 targeted population in Haining]. Jiang CX; Wang XP; Shen YZ Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):707-711. PubMed ID: 28926902 [No Abstract] [Full Text] [Related]
59. [Medicinal prevention of gastrointestinal tumors: aspirin, Helicobacter and more?]. Becker JC; Domschke W; Pohle T Internist (Berl); 2006 Dec; 47(12):1229-30, 1232-4, 1236-8. PubMed ID: 17075707 [TBL] [Abstract][Full Text] [Related]